Fulminant hepatic failure associated with propylthiouracil: A case report with treatment emphasis on the use of plasmapheresis

被引:17
作者
Aydemir, S [1 ]
Ustundag, Y
Bayraktaroglu, T
Tekin, IO
Peksoy, I
Unal, AU
机构
[1] Zonguldak Karaelmas Univ, Fac Med, Dept Gastroenterol, TR-67800 Zonguldak, Turkey
[2] Zonguldak Karaelmas Univ, Fac Med, Dept Internal Med, TR-67800 Zonguldak, Turkey
[3] Zonguldak Karaelmas Univ, Fac Med, Dept Immunol, TR-67800 Zonguldak, Turkey
[4] Zonguldak Karaelmas Univ, Fac Med, Dept Nucl Med, TR-67800 Zonguldak, Turkey
[5] Zonguldak Karaelmas Univ, Fac Med, Dept Neurol, TR-67800 Zonguldak, Turkey
关键词
propylthiouracil; hyperthyroidism; fulminant hepatic failure; plasmapheresis;
D O I
10.1002/jca.20063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Propylthiouracil is a commonly used medication for hyperthyroidism. Though propylthiouracil-induced hepatotoxicity is a rarely encountered problem, death due to fulminant hepatic failure may occur. In the English literature, only 34 cases have been described with severe hepatotoxicity secondary to this drug. Here We report a case of fulminant hepatic failure due to propylthiouracil and review the issues of treatment and management with special emphasis on the use of plasmapheresis in such situations.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 40 条
[1]   PROPYLTHIOURACIL-ASSOCIATED HEPATITIS [J].
BLOCH, CA ;
JENSKI, LJ ;
BALISTRERI, WF ;
DOLAN, LM .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (11) :2129-2130
[2]  
Clemmesen JO, 2001, AM J GASTROENTEROL, V96, P1217
[3]  
COLDWELL AR, 1952, JAMA-J AM MED ASSOC, V148, P639
[4]   Propylthiouracil-induced fulminant hepatitis: Case report and review of the literature [J].
Deidiker, R ;
deMello, DE .
PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1996, 16 (05) :845-852
[5]   FULMINANT HEPATITIS DURING TREATMENT WITH PROPYLTHIOURACIL [J].
EISEN, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1953, 249 (20) :814-816
[6]   Fulminant hepatitis A in a patient with severe hyperthyroidism: Rapid recovery from hepatic coma after plasmapheresis and total thyroidectomy [J].
Enghofer, M ;
Badenhoop, K ;
Zeuzem, S ;
Schmidt-Matthiesen, A ;
Betz, C ;
Encke, A ;
Usadel, KH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1765-1769
[7]   LIVER-DISEASE CAUSED BY PROPYLTHIOURACIL [J].
FEDOTIN, MS ;
LEFER, LG .
ARCHIVES OF INTERNAL MEDICINE, 1975, 135 (02) :319-321
[8]   PLASMAPHERESIS IN ACUTE LIVER-FAILURE [J].
FREEMAN, JG ;
MATTHEWSON, K ;
RECORD, CO .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1986, 9 (06) :433-438
[9]   HEPATITIS ASSOCIATED WITH PROPYLTHIOURACIL TREATMENT [J].
GARTY, BZ ;
KAULI, R ;
BENARI, J ;
LUBIN, E ;
NITZAN, M ;
LARON, Z .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (10) :740-742
[10]   Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: A case report [J].
Guvenc, B ;
Unsal, C ;
Gurkan, E ;
Dincer, S .
JOURNAL OF CLINICAL APHERESIS, 2004, 19 (03) :148-150